{
    "clinical_study": {
        "@rank": "139806", 
        "brief_summary": {
            "textblock": "Some bacteria that cause disease can produce toxic substances that may worsen the disease.\n      Pseudomonas aeruginosa is a bacteria that can produce a variety of toxins and is of special\n      interest for patients with cystic fibrosis and repeated long term lung infections.\n\n      The goal of this study is to determine whether specific toxins produced by Pseudomonas\n      aeruginosa may be important in the disease process of chronic lung infections of patients\n      with cystic fibrosis.\n\n      This study will attempt to measure bacterial production of toxins in blood and sputum and\n      immune system response to toxins in the blood."
        }, 
        "brief_title": "Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa", 
        "condition": [
            "Pseudomonas Infection", 
            "Cystic Fibrosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis", 
                "Pseudomonas Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "The goal of this study is to determine whether virulence determinants that use the type\n      III-secretory pathway may be important in the pathogenesis of chronic Pseudomonas aeruginosa\n      lung infections in patients with cystic fibrosis (CF).  The studies will quantify bacterial\n      effector proteins in serum and sputum and the immune response to specific products as\n      reflected by antibodies in serum.  Candidate effector proteins include: (1) exotoxin A, a\n      non-type III-dependent ADP-ribosyltransferase and cytotoxin that does not use the Type III\n      secretory pathway, (2) ExoS, a type III pathway-dependent extracellular\n      ADP-ribosyltransferase with cytotoxic activity, (3) ExoU, another type III-dependent\n      cytotoxin, that is responsible for epithelial injury in acute lung infections, and (4) PcrV,\n      a homolog to the V antigen of Yersinia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Patients with cystic fibrosis with a defined mutation in the cystic fibrosis transmembrane\n        regulator (CFTR) (e.g., any of the known variants of the CFTR gene, such as the delta F508\n        allele).\n\n        Patients will have been tested or will  be tested for the CFTR gene under another\n        protocol.\n\n        Research volunteers that are age-and race-matched as control subjects.\n\n        EXCLUSION CRITERIA:\n\n        Patients who are less than 9 years of age.  Research volunteers less than 18 years of age.\n\n        Patients or research volunteers who test positive for human immunodeficiency virus (HIV)\n        or a positive serum test for hepatitis B and/or C virus.\n\n        Patients or research volunteers who test positive for tuberculosis.\n\n        Research volunteers with pulmonary disease or infection."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "9 Years"
        }, 
        "enrollment": {
            "#text": "225", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00027183", 
            "org_study_id": "980062", 
            "secondary_id": "98-H-0062"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cystic Fibrosis", 
            "Effector Proteins", 
            "Cytotoxin", 
            "Lung Injury", 
            "Genetic Screen"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1998-H-0062.html"
        }, 
        "location": [
            {
                "contact": {
                    "email": "prpl@mail.cc.nih.gov", 
                    "last_name": "For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)", 
                    "phone": "800-411-1222", 
                    "phone_ext": "TTY8664111010"
                }, 
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20892"
                    }, 
                    "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98195"
                    }, 
                    "name": "University of Washington - Cystic Fibrosis Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }, 
                    "name": "Medical College of Wisconsin"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa", 
        "overall_contact": {
            "email": "mhaughey@nhlbi.nih.gov", 
            "last_name": "Mary Haughey, R.N.", 
            "phone": "(301) 496-3632"
        }, 
        "overall_contact_backup": {
            "email": "mossj@nhlbi.nih.gov", 
            "last_name": "Joel Moss, M.D.", 
            "phone": "(301) 496-1597"
        }, 
        "overall_official": {
            "affiliation": "National Heart, Lung, and Blood Institute (NHLBI)", 
            "last_name": "Joel Moss, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "9302017", 
                "citation": "Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SM, Wu C, Mende-Mueller L, Frank DW. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol. 1997 Aug;25(3):547-57."
            }, 
            {
                "PMID": "8460141", 
                "citation": "Fu H, Coburn J, Collier RJ. The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2320-4."
            }, 
            {
                "PMID": "9427393", 
                "citation": "Frank DW. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol. 1997 Nov;26(4):621-9. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00027183"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 1998", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }, 
    "geocoordinates": {
        "Medical College of Wisconsin": "43.039 -87.906", 
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095", 
        "University of Washington - Cystic Fibrosis Center": "47.606 -122.332"
    }
}